Clinical characteristics and outcomes of patients with severe covid-19 with diabetes

被引:353
|
作者
Yan, Yongli [1 ]
Yang, Yan [1 ]
Wang, Fen [1 ]
Ren, Huihui [1 ]
Zhang, Shujun [1 ]
Shi, Xiaoli [1 ]
Yu, Xuefeng [1 ]
Dong, Kun [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Endocrinol, Wuhan, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
adult diabetes; GLYCOSYLATION; CORONAVIRUS; PLAYS;
D O I
10.1136/bmjdrc-2020-001343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study explores the clinical characteristics of patients with diabetes with severe covid-19, and the association of diabetes with survival duration in patients with severe covid-19. Research design and methods In this single-center, retrospective, observational study, the clinical and laboratory characteristics of 193 patients with severe covid-19 were collected. 48 patients with severe covid-19 had diabetes, and 145 patients (ie, the controls) did not have diabetes. A severe case was defined as including at least one of the following criteria: (1) Respiratory rate >30/min. (2) Oxygen saturation <= 93%. (3) PaO2/FiO(2)<= 300mm Hg. (4) Patients, either with shock or respiratory failure, requiring mechanical ventilation, or combined with other organ failure, requiring admission to intensive care unit (ICU). Results Of 193 patients with severe covid-19, 48 (24.9%) had diabetes. Compared with patients with severe covid-19 without diabetes, patients with diabetes were older, susceptible to receiving mechanical ventilation and admission to ICU, and had higher mortality. In addition, patients with severe covid-19 with diabetes had higher levels of leukocyte count, neutrophil count, high-sensitivity C reaction protein, procalcitonin, ferritin, interleukin (IL) 2 receptor, IL-6, IL-8, tumor necrosis factor alpha, D-dimer, fibrinogen, lactic dehydrogenase and N-terminal pro-brain natriuretic peptide. Among patients with severe covid-19 with diabetes, more non-survivors were men (30 (76.9%) vs 9 (23.1%)). Non-survivors had severe inflammatory response, and cardiac, hepatic, renal and coagulation impairment. Finally, the Kaplan-Meier survival curve showed a trend towards poorer survival in patients with severe covid-19 with diabetes than patients without diabetes. The HR was 1.53 (95% CI 1.02 to 2.30; p=0.041) after adjustment for age, sex, hypertension, cardiovascular disease and cerebrovascular disease by Cox regression. The median survival durations from hospital admission in patients with severe covid-19 with and without diabetes were 10 days and 18 days, respectively. Conclusion The mortality rate in patients with severe covid-19 with diabetes is considerable. Diabetes may lead to an increase in the risk of death.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Characteristics of COVID-19 Patients With Thrombosis and Impact on Clinical Outcomes
    Case, Brian
    Abramowitz, Jonathan
    Shea, Corey
    Rappaport, Hank
    Medranda, Giorgio
    Yerasi, Charan
    Chezar-Azerrad, Chava
    Zhang, Cheng
    Satler, Lowell
    Itsik, Ben-Dor
    Hashim, Hayder
    Rogers, Toby
    Weintraub, William
    Waksman, Ron
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (19) : B26 - B27
  • [22] Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD
    Turan, Onur
    Yigitbas, Burcu Arpinar
    Turan, Pakize Ayse
    Mirici, Arzu
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (08) : 1069 - 1076
  • [23] Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD
    Turan, Muzaffer Onur
    Yigitbas, Burcu Arpinar
    Turan, Pakize Ayse
    Mirici, Arzu
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [24] Clinical characteristics and outcomes of COVID-19 patients in Bali, Indonesia
    Masyeni, Sri
    Nelwan, Erni Juwita
    Fatawy, Rois Muqsith
    Wibawa, Surya
    Nugraha, Putu Arya
    Antara, Jarwa
    Suparta, Adi
    Asmara, D. G. Wedha
    Yenny, L. G. Sri
    Budhitresna, A. A. G.
    Arimas, Dewi
    Indriani, Dewi
    Parwata, Kmg
    Sutarjana, Ketut
    Sugiartha, Eka
    Kahari, Siska
    Wardhana, Clareza Arief
    Indraningrat, A. A. G.
    Mulyantari, Kadek
    Pasek, Arya Widiyana
    Putrawan, Oka
    Yustiani, Nyoman Trisna
    Wardana, Gede
    Wijaya, Made Indra
    Aryana, Suka
    Gayatri, Yuli
    Sukmawati, Dewi Dian
    Suastika, Ketut
    Merati, Tuti Parwati
    Bakta, Made
    Widiana, Raka
    [J]. PLOS ONE, 2022, 17 (06):
  • [25] Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
    Chen, Yuchen
    Yang, Dong
    Cheng, Biao
    Chen, Jian
    Peng, Anlin
    Yang, Chen
    Liu, Chong
    Xiong, Mingrui
    Deng, Aiping
    Zhang, Yu
    Zheng, Ling
    Huang, Kun
    [J]. DIABETES CARE, 2020, 43 (07) : 1399 - 1407
  • [26] Clinical Characteristics and Outcomes of Type 2 Diabetes Patients Infected with COVID-19: A Retrospective Study
    Chen, Yingyu
    Chen, Jiankun
    Gong, Xiao
    Rong, Xianglu
    Ye, Dewei
    Jin, Yinghua
    Zhang, Zhongde
    Li, Jiqiang
    Guo, Jiao
    [J]. ENGINEERING, 2020, 6 (10) : 1170 - 1177
  • [27] Microvascular disease in diabetes and severe COVID-19 outcomes
    Corcillo, Antonella
    Whyte, Martin B.
    Vas, Prashanth
    Karalliedde, Janaka
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (04): : 200 - 201
  • [28] Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes
    Al-Baadani, Abeer
    Eltayeb, Nazik
    Alsufyani, Eid
    Albahrani, Salma
    Basheri, Shareefah
    Albayat, Hawra
    Batubara, Enas
    Ballool, Sulafa
    Al Assiri, Ayed
    Faqihi, Fahad
    Musa, Ali B.
    Robert, Asirvatham A.
    Alsherbeeni, Nisreen
    Elzein, Fatehi
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (08) : 1021 - 1027
  • [29] Characteristics and outcomes of COVID-19 positive patients with diabetes managed as outpatients
    Shabto, Julie M.
    Loerinc, Leah
    O'Keefe, Ghazala A.
    O'Keefe, James
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 164
  • [30] Clinical Outcomes and Prevalence of Sarcopenia in Patients with Moderate to Severe COVID-19
    Yamamoto, Shuhei
    Sakai, Yasunari
    Matsumori, Keiji
    Osawa, Ryuji
    Ito, Shun
    Tsukakoshi, Daichi
    Ohno, Tomoki
    Ohta, Hiroaki
    Ichiyama, Takashi
    Komatsu, Masamichi
    Wada, Yosuke
    Hanaoka, Masayuki
    Ikegami, Shota
    Horiuchi, Hiroshi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)